Bioasis Technologies Inc.Bioasis Technologies Inc.Bioasis Technologies Inc.

Bioasis Technologies Inc.

No trades
See on Supercharts
Market capitalization
‪287.90 K‬USD
‪77.78 M‬
Beta (1Y)
−0.15

About Bioasis Technologies Inc.

CEO
Deborah A. Rathjen
Website
Headquarters
New Haven
Founded
2006
ISIN
CA09064N1033
FIGI
BBG000VNSZF0
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOAF is 0.01 USD — it has decreased by 37.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioasis Technologies Inc. stocks are traded under the ticker BIOAF.
Bioasis Technologies Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOAF earnings for the last quarter are −0.01 USD whereas the estimation was −0.02 USD which accounts for 50.00% surprise. Estimated earnings for the next quarter are −0.01 USD. See more details about Bioasis Technologies Inc. earnings.
Bioasis Technologies Inc. revenue for the last quarter amounts to ‪3.13 M‬ USD despite the estimated figure of ‪191.87 K‬ USD. In the next quarter revenue is expected to reach ‪231.50 K‬ USD.
Yes, you can track Bioasis Technologies Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BIOAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioasis Technologies Inc. stock right from TradingView charts — choose your broker and connect to your account.
BIOAF reached its all-time high on Sep 12, 2012 with the price of 2.11 USD, and its all-time low was 0.00 USD and was reached on Dec 7, 2023.
See other stocks reaching their highest and lowest prices.